Rodrigo Cerda, M.D.., M.P.H., of Independence Blue Cross in Philadelphia Discusses New Role and the Latest on Value-based Care, SDOH and Covid-19

Briana Contreras, editor of Managed Healthcare Executive spoke with Luis Mosquera, CEO of Health Network One, a provider of specialty benefit management services for health insurers, in this week's episode. In this discussion, Luis and Briana talked about how value-driven decisions in a more value-based market can not only better manage costs for health plans, but create a plan of care to best meet patient’s needs. In order to do this, Luis strongly encouraged healthcare executives to experience alternative payment models and shared what payers should check off their list with a new model.

Pfizer's COVID-19 vaccine, Comirnaty, dominated in 2022 with forecast sales of $37 billion. The vaccine is expected to maintain these sales going into the future, with with sales forecasts up by 16%.

A 72-year-old man developed worsening myalgia while taking Paxlovid. The FDA and authors of a case report in JAMA Internal Medicine today says patients who would benefit from Paxlovid should be advised to temporarily stop taking statins and other drugs with potentially serious drug-drug interactions with Paxlovid.

Healthcare leaders are urging the public in a new public service announcement to make sure they are up-to-date on their COVID-19 vaccines, including the updated bivalent booster dose when eligible.